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Plasma exhibits an ability to neutralize or destroy the characteristic prote- 
olytic action of active plasmin. The importance of irthibitors has been realized 
in  evaluating  the  function  of  the  plasmin  system;  but  the  nature  of blood 
inhibitors is poorly understood and has been the subject of differing observa- 
tions. 
A rather slow, temperature-dependent inhibition was described  by Guest, Daly, 
Ware, and Seegers (1), as well as by Ungar and Damgaard (2). On the other hand, 
Shulman  (3), Jacobsson  (4),  and Thomas and Dingle (5) have reported rapid and 
apparently stoichiometric reactions that did not particularly depend on temperature. 
Grob (6) found a rapid but reversible inhibition of plasmin  by serum and, more re- 
cently, Shulman (7) isolated a low molecular weight inhibitor from plasma and urine 
which also reacted rapidly and reversibly,  but which accounted for only a small por- 
tion of inhibitor activity of whole plasma.  Meyers and Burdon found that the varia- 
tions in proteolytic activity of dilutions  of whole serum  activated by streptokinase 
suggested  a dissociable inhibitor (8). These apparently conflicting observations may 
be reconciled by the suggestion of Ratnoff that there are several plasmin  inhibitors 
in blood with differing actions  (9). Subsequently, Ratnoff, Lepow, and Pillemer have 
given evidence for at least three inhibitors in plasma. In their experiments, one plasma 
component was  destroyed by heating at 56  ° for 30 minutes.  The remaining  heat- 
stable inhibitor they further subdivided on the basis that part of the inhibitory power 
was  inactivated by ammonia and primary amines,  leaving  a  component stable to 
both heat and these chemicals (10). 
The present investigation restudies the mode of action of plasma inhibitors 
on plasmin,  using  the recently described caseinolytic assay  (11).  By several 
methods kinetic evidence was found for two inhibitory components for plas- 
rain, one acting rapidly but reversibly, the other acting more slowly and at a 
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rate  that  depends on temperature.  I The methods  of  study were more direct 
than those used by previous investigators, in that a  partially purified human 
plasmin was prepared free of activators (12), so that a known amount of plas- 
rain was added to plasma in order to follow the inactivation of plasmin under 
varying conditions. Part of this work was done before a purified active plasmin 
was available and a more complicated system was used, wherein streptotdnase- 
activated  plasminogen  reacted  with  serum  that  had  had  its  plasminogen 
removed. In a  subsequent paper, the physical separation of the two proposed 
inhibitory components will be described and methods given for their individual 
estimation in whole plasma. 
Materials and Methods 
Plasminogen.--Human  plasma fraction III was used as the starting material  * in prepara- 
tion of plasminogen by Kline's method (13). The plasminogen powder was dried with alcohol 
and ether according to Cliffton and Cannamela (14). 
Streptokinase.--Varidase  (lot ~ 2200-10173), a lyophllized  mixture of streptococcal enzymes 
consisting of streptokinase, streptodoruase, other protein,  and phosphate buffer was kindly 
furnished by the Ledefle Laboratories Division, American Cyanamid Company. This material 
contained about 4000 Christenson units of streptokinase per nag. 
Plasmln.--Preparation of active plasmin from plasminogen has been described in detail 
elsewhere (12). Briefly, 400 mg. human plasminogen was dissolved in 200 ml. borate-saline 
buffer, pH 7.4, and 3.0 rag. streptokinase added. After incubation for 30 minutes at 25°C., 
200 ml. 2 •  NaC1 was added and the pH adjusted to 2.0 with N HCL The resulting precipi- 
tate was separated by centrifugation, washed twice with 1 ~  NaC1 at pH 2.0, and finally 
dried with alcohol and ether. The resulting white powder was stable at 5°C. for at least a year. 
It was highly soluble and stable in 0.0025 ~ HC1, but poorly soluble and unstable in neutral 
salt solutions. The plasmiu preparations used in these experiments had specific activities of 
more than 80 X  10  -8 caseinolytic units per rag. When solutions of plasmin in buffer were 
needed, a concentrated stock solution was made in 0.0025 ~ HC1 and diluted to the desired 
strength with buffer at the beginning of the experiment. 
Plasminogen-Free Serum.--Normal guinea pig or human serum was dialyzed against dis- 
tilled water for 24 hours at 5°C. The dialyzed serum was diluted to twice original volume with 
distilled water, and the reaction adjusted to pH 5.2 by glass electrode with 5 per cent acetic 
acid. The resulting eugiobulin precipitate was allowed to ripen 30 minutes at 5°C. and sepa- 
rated by centrifugation at 1500 R.P.M. for 15 minutes and discarded. The reaction of the clear 
supernatant was readjusted to pH 7.4 with N NaOH. Serum so prepared was discarded after 
1 week's storage at 5°C. if not used. 
ttuman Plasma.--Citrated whole human blood rejected for reasons of insufficient collec- 
tion or positive serologic  test for syphilis was obtained from theblood bank of The Johns Hop- 
kins Hospital. Using aseptic technique, the plasma was drawn off from the settled red cella 
and any remaining cells and precipitated fibrin separated by centrffugation. Several units of 
plasma so prepared were pooled and dispensed into sterile 10 ml. screw top vials and stored 
at 5°C. At the time of use any new fibrin precipitate which had formed was removed by cen- 
trifugation. 
t Preliminary reports of parts of these studies appeared in Fed. Proc., 1956, 15, 606, and 
in Clin. Research Fror. 1957, 5, 155. 
Human fraction III supplied by E. R. Squibb and Sons, Corporation, through the courtesy 
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As an alternative method, fresh blood was collected by venipuncture, and each 10 ml. blood 
added to a centrifuge tube containing 0.3 ml. 5 per cent disodium versenate (disodium ethylene- 
diamine tetra-acetate) as an anticoagulant. Plasma was separated by centrifugation and used 
on the day of collection. Fresh versenated plasma showed slightly greater plasmin inhibitory 
capacity than stored dtrated plasma, but the nature of the inhibition was not significantly 
different. 
Assay of Plasmin.--The previously described caseinolytic method was used for determina- 
tion of residual plasmin (11). The method originally described employed a single addition of 
3.0 ml. 10 per cent trichloroacetie add; it now has been modified slightly in that 0.5 ml. 15 
per cent trichioroacetic acid is used to stop the reaction, and after about 10 minutes, an addi- 
tional 2.5 ml. 15 per cent trichloroacetic acid is added. The precipitates are allowed to stand 
overnight at 5°C. to permit complete precipitation. The two stage precipitation is needed when 
whole plasma or serum is present, in order to obtain consistent values for reagent blanks. 
Buffer.--Borate-sallne buffer, pH 7.4, as described by Palitzseh (15) was used throughout. 
This was prepared by mixing 0.05 g  sodium borate (19.108  gin. Na2B4OT. 10I-I20 per liter of 
distilled water) with 0.2 ~  boric acid-salt solution (12.404 gin. I-I~BO3  and 2.925 gin. NaC1 per 
liter of distilled water) until pH 7.4 was obtained by glass electrode. Approximately 1.2 parts 
borate solution to 8.8 parts boric acid-salt solution were required. 
Methylamine.--c.P. methylamine hydrochloride was dissolved in borate-saline buffer and 
pH adjusted to 7.4 with N HC1 or r~ NaOH. 
EXPERIMENTAL 
In a  preliminary experiment,  whole human plasma  was  warmed  to 37°C. 
and 0.1 mg. streptokinase was added per ml. of plasma. The appearance and 
disappearance of proteolytic activity was followed by removal of 1.0 ml. ali- 
quots for casein digestion. The appearance of protease was apparently instan- 
taneous and was followed by a progressive loss of activity so that it was barely 
detectable  after 5 minutes. Furthermore,  the maximum activity from whole 
plasma was only about one-half that obtained from the separated euglobulin 
of the same plasma. Two important facts are obtained from this simple experi- 
ment. First, despite the rapid action of streptokinase, inhibitors prevent the 
appearance of the full potential protease in the plasma. Second, at body tem- 
perature, plasma is capable of inactivating all of its own content of plasmin 
after a brief period. 
The following experiments were designed to explore the nature of rapid and 
effective plasmin inhibition by whole plasma. As it was difficult to determine 
accurately the plasmin content of whole serum, a  procedure that gave better 
results was employed: a predetermined amount of plasmin was added to serum 
or plasma, and the decay of proteolytic activity was observed. In the experi- 
ments to be described next, this was done with purified plasminogen activated 
with streptokinase. The streptokinase in the mixture, however, caused activa- 
tion of plasminogen in whole serum and plasma, so it was necessary to prepare 
serum free of plasminogen by removing the  "globulin," in order to test the 
inhibitory mechanism without the simultaneous occurrence of activation re- 
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After equilibration in a constant temperature water bath,  1.6 ml. borate-saKue buffer con- 
taining 0.15 rag. streptokinase was added to 8.0 ml. buffer cont-(n~ng 5.5 rag. purified plasmino- 
gen. Depending upon the temperature to be tested, activation was allowed to occur for either 
5 minutes at 37°C. or 20 minutes at 25°C. Then, 8.0 ml. plasminogen-free guinea pig or hu- 
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FIG.  1.  Detefioration of purified human pla~rn~uogen acfivated with streptoldnase and held 
at the indicated temperatures at pH 7.4. The upper fine of each pair shows the enzyme in 
buffer alone, while the lower line shows the same amount of plasrnin in the presence of euglob- 
uUn-free guinea pig serum. 
man seru~ diluted 1/4 with buffer was added, and timing begun. Control reactions were done 
with the serum replaced by buffer. During incubation, 1.1 ml. aliquots were removed and added 
to 1.0 ml. previonsly warmed 4.0 per cent ca.~ein at 37°C. for determ{n-fion of residual plas- 
rain. Fig. 1 illustrates the results of two such experiments with guinea pig serum. 
Plasmin  had an inactivation rate of its own that was considerable at 37°C., 
but very small at  25°C.  In either case, upon  the addition  of serum,  there  was Pm~n, s.  ~om~a~  57 
an  immediate loss of activity which occurred  too rapidly for rate  measure- 
ment, followed by a  slower but progressive inhibition which proceeded over 
the entire period measured. The second reaction appeared to be more rapid at 
37°C., and this fact suggested that it depended on temperature. The depend- 
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FIG. 2. Rate of inhibition of samples of purified human  pI~'-inoge~ activated with strep- 
tokinase and held  at different  temperatures. At 0 time euglobulin-free  guinea  pig serum added. 
Per cent inhibition calculated  from the difference  between the partially inhibited plasmin  and 
plasmin incubated at the same temperature in buffer alone. 
ence of the reaction on temperature was further tested by doing slmiIar experi- 
ments at 0°C. and 30°C., with a  result that demonstrated the suggested two 
stage reaction more fully. 
Fig. 2 illustrates the per cent plasmln inhibited with time at each tempera- 
ture.  Percentages  were  calculated using values of plasmin  determined from 
controls  in  which  there  was  no  serum.  At  all  temperatures  the  immediate 
inhibition was  the same,  but  the  slow reaction  was highly temperature-de- 58  BIDDIES  O1~  PLASMIN  SYSTEm.  II 
pendent, being nil at O°C., and increasing rapidly with increase in temperature. 
The same experiments were also done with human serum and entirely com- 
mensurate results were obtained, with slightly less content of both inhibitors. 
On the basis of these rather crude experiments, which were complicated by 
the concomitant occurrence of self-inactivation of plasmin, it seemed possible 
that  there are  two  substances  in  guinea  pig and  human  serum  which  have 
differing modes of action on plasmin.  On the basis  of their relative speed of 
action, these hypothetical substances are referred to in the remainder of the 
paper as the "immediate" inhibitor and the "slow" inhibitor. 
Immediate Inhibitor 
The following experiments examine the early reaction in more detail.  For 
this work, a  way of using unaltered serum or plasma was sought,  as the re- 
moval of the globulin from the serum might change the remaining proteins. 
Active plasmin free of streptokinase was prepared by the method previously 
reported (12) and was found not to activate purified plasminogen during sev- 
eral hours  at  25°C.  This  material  could be  added  to plasma  and  the  plas- 
minogen in the plasma would not be activated, at least, not during the rather 
short time of observation. When plasmin without streptokinase was added to 
whole plasma, the twofold reaction just described was again seen. Plasma ex- 
hibited somewhat greater inhibition than serum, so plasma was used in pref- 
erence to serum in the remaining experiments. 
The evidence that there are two inhibitory reactions, one rapid and one slow, 
depends on the assumption that the second or slow reaction is stopped by the 
addition of substrate for the determination of residual plasmin. If the inhibitor 
continued to act on the enzyme during the course of the 30 minute digestion 
period necessary for assay, falsely high values for inhibition would be obtained, 
and the apparent immediate inhibition would be an artifact that results from 
the assay method. It seemed possible to assess such an effect by testing whether 
plasmin held partially inactivated by the presence of inhibitor would behave 
differently from plasmin used alone. Digestion of 2 per cent casein by plasmin 
is linear up to an optical density of 0.350 (11). If plasmin in the presence of 
inhibitor also digests casein in a linear fashion, it would be reasonable to con- 
clude that no change in plasmin concentration occurs during the assay period. 
Experiments were undertaken to determine this point. 
A mixture of 20 nal. 4.0 per cent casein, pH 7.4, 4.0 naL human plasma, and 6.0 nal. borate- 
saline buffer was prepared and warmed to 37°C. Then, 10 nal. 0.0025 ~r HC1 containing 6.0 nag. 
plasnain was added and timing begun. The chosen quantity of plasma is sufficient  to inhibit 
this amount of plasnain partially, but not completely.  A control was set up consisting of 20 nal. 
4.0 per cent casein, 10 nal. buffer, and 10 nal. 0.0025 ~ HC1 containing  4.0 nag. plasmin. During 
incubation 2.0 nal. aliquots were removed from each tube and precipitated with 3.0 nal. 15 
per cent trichloroacetic acid added in 2 steps. Optical density of the clear supematant was 
read at 280 na/~ after centrifugation.  Fig. 3 shows the increase  in optical density obtained from 
the two digestion mixtures. rm,J1~  S.  NORMAN  59 
The course of digestion of casein by partially inhibited plasmin showed the 
same  linear  nature  as  that  of  plasmin  without  inhibitor.  The  initial lag in 
digestion has been observed by others  (8) and is explained by Christensen as 
being due to plastein formation (16). This experiment and several others with 
the  same  result  indicated  that  there  was  no  further  inactivation of plasmin 
during the assay procedure, and gave a  sounder basis for the next experiments 
with early inhibitor. 
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FIo. 3.  Digestion of casein by plasmin alone, and by plasmin partially inhibited with hu 
man plasma as measured  by the incr case in optical density of trichioroacetic acid filtrates 
To a  series of tubes containing 1.0 ml. 4.0 per cent casein,  pH 7.4, was added various 
amounts, up to 0.S ml., of whole fresh versenated human plasma. The volume was made up to 
1.5 ml. with borate-saline buffer. The tubes were warmed to 37~C., and 0.S ml. of plasmin in 
0.0025 ~¢ HC1 was added to each. Two series were made, one containing 15.3 X  10-* units 
(0.175 rag.), and the other, 8.8 X  10  -8 units (0.100 rag.) of plasmin per tube. After exactly 30 
minutes of digestion,  the reaction was stopped by adding 1S per cent trichioroacefic add in 
the usual manner. Appropriate  blanks were made by adding trich]oracetic  acid before plasmin. 
The residual uninhibited plasmin was determined from the optical densities of the clear super- 
natant fluids.  The amount of plasmln inhibited was equal to the original plasmln (8.8 or 
15.3 X  10  -8 units) less the residual plasmin. The results are shown in Fig. 4. 
The  curves  show  decreasing increments  of inhibition with  each  increment 
of plasma. Also, more inhibition occurred  when  more plasmin was  presented 
for inhibition. These facts suggest a  reversible reaction not going to comple- 
tion. The  Kunitz formula  (17)  was  used to calculate theoretical curves for a 50  STUD'r~-s  OF  PLA.~.rr~  SYSTEM,  II 
dissociable combination under the above  conditions,  and only partial agree- 
ment between  the mass  action curve  and experimental  values was  obtained 
which was not close enough to suggest a simple reversible reaction of the sort 
observed  by others with purified inhibitors (7,  17). It seems likely that the 
reaction of whole plasma with plasmin is too complex for easy mathematical 
analysis,  but the reversibility  of the combination may be tested in another 
way. It may be shown that the inhibition becomes less with higher concentra- 
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FIo. 4.  Immediate inhibition of two concentrations of purified pla.qmi, by varying amounts 
of whole human plasma. Plasrnin was added to plasma with casein already present. 
tions of substrate, indicating that the substrate competes  with inhibitor for 
enzyme. 
Standard plasmln curves were prepared  for final concentrations of 1.0 and  3.0 per cent 
casein by the method described in the previous paper (11). Another early inhibition experiment 
was done comparing inhibition by plasma in the presence of 1.0 and  3.0 per cent casein. 
15 X  10-8 units plasmin was used per tube. 
The curves in Fig. 5 show that inhibition by the same amount of plasma 
was less when more substrate was present.  They suggest competition between 
a plasma component  and casein substrate for the active site on the enzyme, 
and support the conclusion that the reaction is reversible. PHILIP  S.  NORMAN  61 
Meyers and Burdon were probably studying the same reaction when they 
activated a series of dilutions of human serum with streptokinase in the pres- 
ence  of casein or hemoglobin,  and  then followed the  course  of proteolysis. 
They also  arrived  at  the  conclusion that  there  is  a  dissociable inhibitor in 
serum, because, with increasing serum concentrations, proteolytic activity did 
not increase proportionately (8). 
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FIo.  5.  Immediate inhibition of a  single concentration of purified plasmin by whole hu- 
man plasma in the presence of two different concentrations of casein. 
Slow Inhibitor 
Purified plasmin was next used in a  study of the slow inhibitor of plasma. 
It has already been pointed out that plasmin is autodigestive at neutrality, 
and this process has been described in detail elsewhere (12).  This represented 
a complicating side reaction which interfered with the observation of inhibition 
by plasma over a  period of time.  In  the report  on autoinactivation, it was 
shown  that  either  methylamine or  urea  would  check  the  autodigesfion of 
plasmin by the ability of these substances to inhibit proteolysis. Subsequent 62  STUDIES  OF  PLASMIN  SYSTEm.  II 
experiments demonstrated that plasmin incubated at 25°C.  with a  2 ~  con- 
cent.ration of either compound was stable over many hours. It was also found 
that, although urea interfered with inhibition, 2 ~r methylamine allowed slow 
inhibition due to plasma to occur apparently unhindered. Thus, it was possible 
to follow the rate of slow inhibition at 25°C. while the auto-inhibition of plas- 
mln was being suppressed by methylamine. Because methylamine inhibits the 
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FIG.  6.  Tn~ibition at 25°C.  of 4.0 rag. plasmin stabilized with methylamine by varying 
quantities of whole human plasma, as indicated by measurements of residual plasmin in aU- 
quots removed from the reaction mixture at various times. 
proteolytic activity of plasmin, it was necessary to dilute it to 0.i M for deter- 
minafions of plasmin activity. This was done by allowing the reaction between 
plasma and a  relatively concentrated solution d  plasmin to proceed in  2 
methylamine. For  purposes  of measurement,  aliquots  of only 0.I  ml.  were 
removed and diluted 20 times so that the concentration d  methylamine would 
be  0.I  M during casein digestion. Low concentrations of methylamine were 
still slightly inhibitory to plasmin, but correction was made for this as de- 
scribed below. 
Two sets of proteolytic determinations were done on a series of dilutions of a preparation of 
plasmin, one set with 0.i ~  methylamine in the digestion mixture, and one set without. From p~Tt.IP  S.  NORMAN  63 
the determinations done without methylamine the plasmin was found to have 83.4  X  10-~ 
easeinolytic units per mg, This value was used to plot a second standard curve, with abscissae 
expressed in units, i  rag. plasmin being equal to 83.4 X  10-s units, while the ordinates were 
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Fro.  7.  Inhibition at 25°C. of varying quantities of plasmin stabilized with methylamine 
by 0.225 ml. whole human plasma, as indicated by assays of residual plasmin in aliquots re- 
moved at various times. Plasmin added indicated by the figures at right. Dotted lines are con- 
trols without plasma; solid lines are observations with plasma. 
the optical densities obtained from digestion by the several amounts of plasmin in the pres- 
ence of 0.1 M methylamine. When this curve was used, plasmin unknowns could be expressed 
in the same unit system used heretofore, although determinations were actually done in the 
presence of 0.1 M methylamine. 
The rate of inactivation of pla.~min by a series of dilutions of plasma was measured as fol- 
lows: Dilutions of normal human citrated plasma in borate buffer were prepared in these pro- 64  STUDIES OF  PLASMIN SYSTEM. II 
portions: undiluted,  1/2, 1/4, 1/8,  1/16, 1/32, 1/64, and buffer alone. Tubes containing 0.9 
ml. of the various dilutions were prepared and to each was added 0.9 ml. of 4.4 ~r methylamine. 
The tubes were warmed to 25°C. in a constant temperature water bath, and in carefully timed 
sequence 0.2 ml. 0.0025 M HCI containing 4.00 rag. plasmin was added to each) This gave a 
final concentration of 2.0 ~r methylamine and 2.0 mg./ml, plasmin. At intervals, over a period 
of 260 minutes, 0.1 ml. aliquots were removed for determination of residual plasmin and added 
to a digestion mixture of 1.0 ml. 4.0 per cent casein and 0.9 ml. buffer already warmed to 37°C. 
Mter 30 minutes the caseinolyfic reaction was stopped by trichloroacetic acid, as already de- 
scribed, and optical densities of the clear supernates were read at 280 m4~. The units of plasmin 
present was read from the calibration curve for 0.1 ~ methylamine described in the preceding 
paragraph. 
In order to test the effect of plasrnin concentration  on the rate of inactivation,  a similar 
experiment was done with.a 1/4 dilution of plasma, and the added plasmin was varied be- 
tween 1.0 and 6.0 rag. (final concentrations of plasmin, 0.5 to 3.0 mg./ml.). 
The  results  of the  two  experiments  are  shown  in  Figs.  6  and  7.  Residual 
plasmin  is  expressed  as  the  units  remaining  in  the  2.0 ml.  mixture  held  at 
25°C. and was calculated from protease determinations on the 0.1 mi. aliquots. 
Controls without plasma axe indicated  by dotted lines,  while solid lines show 
inactivation in the presence of plasma. The amount of the varied component 
in  the  plasma-plasmin  mixture  is  indicated  by  the  figures  at  the  right.  The 
initial  difference between the control and the experimental  observation repre- 
sents the effect of the "immediate" inhibitor.  The difference between the first 
experimental  observation on each curve and the remainder of the curve repre- 
sents  the progressive action of slow inhibitor. 
It will be apparent that the rate of inactivation by slow inhibitor depended 
on the  concentration of both plasma  and  of plasmin.  When either  substance 
was increased,  the rate of inactivation as indicated by the initial slopes of the 
curves was increased.  Furthermore,  the reaction seemed to go almost to com- 
pletion,  that  is,  until  one component or the  other was used up.  When  there 
was an excess of plasma, the plasmin was virtually entirely inhibited; the points 
near  the bottom of the  graph represent  the least  amount of protease  detect- 
able  by this  method.  On  the  other  hand,  when  there  was  sufficient plasmin 
present,  the  inactivating  capacity  of plasma  became  exhausted  in  time  and 
no further inhibition occurred. 
Using  those  experiments  in  which  there  was  an  excess  of plasmin,  it  was 
possible  to calculate  the  inhibitory  capacity of a  given sample  of plasma by 
the formula, 
po -  p 
s 
in which Po equals plasmin activity at 0 time, P  equals residual plasmin when 
inactivation  is  complete,  and  S  equals  ml.  of plasma  added.  Table  I  shows 
s Calibrated  Lang-Levy micro pipettes  (Microchemical  Specialties Co.,  Berkeley,  Cali- 
fornia) were used for delivery of volumes of 0.2 ml. or less. PHILIP  S.  NORM.AN  65 
calculations made from this formula with a single specimen of plasma.  4 Within 
experimental errors, the same value for the total inhibitory capacity of this 
plasma was obtained in several experiments in which a variety of concentra- 
tions of both plasma and plasmin were used. 
If  the  reaction between  two  substances  proceeds until  one is  entirely re- 
moved and at a  rate which depends on the concentration of both reactants, 
and if the substances  react in fixed ratio to each other as well,  the circum- 
stances suggest formation of a  molecular combination which is  only slightly 
dissociable and which follows second order kinetics. An attempt was made to 
fit the rate curves just described to the second order formula, but a  different 
constant was obtained for each curve. Whether this dff~culty is merely tech- 
TABLE I 
"Slow" lnhibi~ar Per MI. of a Normal Human Citrated Plasma as Calculated/tom 
Several Experiments 
Plasmln  Plasma 
m&.  mL 
6.0  0.225 
5.0  0.225 
4.0  0.225 
3.0  0.225 
4.0  0.028 
4.0  0.055 
4.0  0.113 
4.0  0.225 
uni~ X  101 
39O 
324 
276 
2O4 
288 
282 
272 
240 
unils X 10  "t 
206 
132 
80 
30 
266 
240 
175 
84 
Po-l' 
usits X 10-* 
184 
192 
195 
174 
22 
42 
96 
176 
Inhibitor per 
ml. plasma 
~m~s x los 
819 
855 
872 
774 
786 
75O 
849 
784 
nical or depends on interfering side reactions is not known. It is possible that 
homogeneous reaction rates  might  be  obtained  ff a  purified  inhibitor  were 
used. Nevertheless, the data thus far obtained suggest a  firm intermolecular 
combination between enzyme and inhibitor which is formed at a measurable 
rate under appropriate  conditions.  It  seems unlikely, therefore, that  "slow" 
inhibitor is  the peptidase described by Ungar  and Adler  (18)  as  correlating 
with the antiplasrnin  property of serum. The possibility still exists, however, 
that the reaction between plasmin and "slow" inhibitor is enzyme catalyzed. 
DISCUSSION 
It  has  not  been noted previously that  the  plasmin-inhibiting  capacity of 
the blood is so much greater than the potential plasmin. In a previous paper 
the pla~mlnogen content of normal human serum or plasma was reported to 
4 The calculation of the inhibitor per ml. plasma did not regularly produce the same re- 
sult when 0.028 or 0.055 ml. plasma was used, because any experimental error in the deter- 
ruination of either Po or P  was so much magnified with small amounts of plasma. 66  STUDIES  O]~  PLASMIN  SYSTEM.  II 
be 25 to 30  X  10  --3 caseinolytic units per ml. In the current study it can be 
seen  that  the  antiplasmin  content  of normal  plasma  (at  least  that  due  to 
"slow" inhibitor) is around 800 X  10  --3 units per ml. The term "slow" is,  of 
course, a  relative one. The dissociable inhibitor of blood acts too rapidly for 
rate measurement,  whereas  rate determinations are possible  on the  non-dis- 
sociable inhibitor at low temperatures in dilute solutions of plasma in the pres- 
ence of a  stabilizer for plasmin. Whereas the rate of combination under these 
conditions  is  indeed  slow,  under  physiological  conditions  (37  °  and  whole 
plasma), inactivation becomes quite rapid and plasma is capable of inhibiting 
its own content of plasmin within a  few minutes. 
It may be asked how plasmin can exert its characteristic proteolytic action 
in the body when so potent an inhibitor is always present. A possible answer 
to such a question is found in the experiments on the effect of a suitable sub- 
strate  on inhibition.  From these experiments, it is  apparent  that  plasmin  is 
protected and  stabilized by a  substrate,  and  this  protection extends  to  the 
point of reversing the action of "immediate" inhibitor and halting the combi- 
nation with "slow" inhibitor. According to present knowledge, fibrin is the most 
likely substance which may be acted on by plasmin in vivo, and in a  recent 
publication,  Celander and  Guest showed  that  fibrin protects active plasmin 
from inhibitors the same as casein does in our experiments (19). Consequently, 
it seems reasonable to postulate that, once activated, plasmin at the site of a 
clot could continue its lyric action until the clot was digested and, only after 
lysis, would the non-dissociable inhibitor rapidly inactivate the enzyme. While 
lysis was  going on,  the dissociable inhibitor would be capable of preventing 
the digestion of proteins for which plasmin has a low affinity. 
These attributes of the plasmin system which seem so ideal for the disposal 
of clots in vivo are suggestive. Up  to this time, however, clot lysing activity 
has been demonstrated by in vitro  observations only, and  there is no direct 
experimental evidence that the system represents a mechanism that the body 
uses for removal of clots. Until such evidence is presented, the possibility re- 
mains  that  clot lysis  is  merely a  laboratory phenomenon and  that  plasmin 
fulfils some other physiological function related to its ability to digest peptide 
or ester bonds. 
In regard to the protective action of substrates, it can be said  that, although fi- 
brinogen is a substrate for plasmin, it was not possible to show that the fibrinogen in 
plasma was protective to plasmin,  and inhibition proceeded as rapidly in plasma as 
in serum.  Celander and Guest have also found that fibrinogen does not prevent in- 
hibition of plasmin by serum (19). Apparently, this is no longer true once the fibrino- 
gen is dotted. 
The present study confirms the suggestion of Ratnoff that there is more than one 
plasmin inhibitor in blood (9). The methods of study used here give evidence for only 
two inhibitors rather than the three postulated by Ratnoff, Lepow, and Pillemer  (10). PHIUP  S. NORMAN  67 
They found two classes of inhibitors on the basis of relative heat stability and, as 
reported in the next paper of this series, the "immediate" inhibitor is more stable to 
heating than the "slow"  inhibitor.  These workers also observed that  more plasmin 
activity was found when any primary amine (including  methylamine) was present 
in an inhibitory system, and they suggested  that a third inhibitor is inactivated by 
these chemicals.  Neither of the inhibitors described  herein is destroyed by methyl- 
amine or hydrazine. The findings  of Ratnoff a  o2.  can  better be explained  by the 
known ability of primary amines to preserve plasmin from auto-inactivation rather 
than by destruction of yet another inhibitor in plasma. 
SI.~WM~.R¥ 
The inactivation of purified plasmin by serum or plasma was studied using 
a  caseinolytic assay for determination of plasmin. On the basis of kinetic evi- 
dence, the presence of two inhibitors in normal human or guinea pig serum or 
plasma is suggested. The first reacts immediately at any temperature,  but is 
easily  dissociable  and  does  not  combine  with  plasmin  in  a  fixed  ratio.  The 
second combines more slowly with plasmin at a  rate which depends on tem- 
perature and on the concentration  of both plasmin and inhibitor.  There is a 
fixed ratio of reaction between plasmin and the second inhibitor and the com- 
bination does not readily dissociate. There is sufficient of the "slow" inhibitor 
in normal plasma to inactivate more than 30 times its own content of potential 
plasmin.  The presence of suitable  substrate  for plasmin tends  to reverse the 
combination  with  "immediate"  inhibitor  and  to  stop  the  further  action  of 
"slow" inhibitor. 
The author wishes to acknowledge the help and advice of Dr. Merrill W. Chase, in whose 
laboratory part of this work was done. 
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